CLINICAL_TRIALS
trial_result
· 2024-08-09
Clinical Trial Update: Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease [Phase 3]
Summary
Phase 3 trial evaluating oral lucerastat as monotherapy in adults with Fabry disease; results assessing efficacy and safety have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Fabry Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-08-09